Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STS | P08842 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 3/20 | 0.44 |
| ▸ | CA5A | P35218 | 2/20 | 0.44 |
| ▸ | ESR1 | P03372 | 2/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.38 |
| ▸ | MAOA | P21397 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 1/20 | 0.37 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.35 |
| ▸ | TYR | P14679 | 1/20 | 0.35 |
| ▸ | TTR | P02766 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA9 | Q16790 | 2/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | APP | P05067 | 1/20 | 0.33 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.33 |
| ▸ | PTPRC | P08575 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29771885 | 1.00 | STS (0.49) | STSCYP3A4CA2CA5AESR1 | |
| Hydrochloric Acid SCHEMBL27538842 | 0.98 | STS (0.47) | STSCYP3A4CA2CA5AESR1 | |
| SCHEMBL16005230 | 0.85 | STS (0.44) | STSESR1ESR2CA9CA12 | |
| SCHEMBL1192912 | 0.84 | CYP3A4 (0.45) | STSCYP3A4CA2CA5AESR1 | |
| SCHEMBL29790627 | 0.84 | CYP3A4 (0.45) | STSCYP3A4CA2CA5AESR1 | |
| SCHEMBL29756778 | 0.81 | CYP3A4 (0.42) | STSCYP3A4CA2CA5AESR1 | |
| SCHEMBL14344128 | 0.79 | CYP3A4 (0.48) | CYP3A4CA2CA5AESR1ESR2 | |
| SCHEMBL276961 | 0.76 | STS (0.53) | STSCA1CA9CA12CYP2B6 | |
| SCHEMBL4150416 | 0.76 | STS (0.49) | STSCA1CA9CA12CYP2B6 | |
| SCHEMBL10426769 | 0.76 | STS (0.53) | STSCA2CA1CA9CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117393035-A | Method for analyzing medicinal components of astragalus glue whitening capsules for treating leukopenia by network pharmacology mode and application thereof | 贵州汉方药业有限公司 | 2024-01-12 | — | — | CN | claimed |
| US-9078891-B2 | 7-hydroxy chromones as potent antioxidants | UNIGEN, INC. (US) | 2015-07-14 | — | — | US | claimed |
| US-20130012458-A1 | 7-HYDROXY CHROMONES AS POTENT ANTIOXIDANTS | UNIGEN, INC. (US) | 2013-01-10 | — | — | US | claimed |
| EP-1503777-B1 | 7-Hydroxy chromones as potent antioxidants | UNIGEN INC (US) | 2012-08-22 | — | — | EP | claimed |
| US-20100168223-A1 | 7-Hydroxy Chromones As Potent Antioxidants | UNIGEN PHARMACEUTICALS, INC. (US) | 2010-07-01 | — | — | US | claimed |
| US-7678772-B2 | 7-hydroxy chromones as potent antioxidants | UNIGEN PHARMACEUTICALS, INC. (US) | 2010-03-16 | — | — | US | claimed |
| EP-1503777-A4 | 7-HYDROXY CHROMONES AS POTENT ANTIOXIDANTS | UNIGEN PHARMACEUTICALS INC (US) | 2008-02-20 | — | — | EP | claimed |
| US-20050164957-A1 | 7-Hydroxy chromones as potent antioxidants | UNIGEN PHARMACEUTICALS, INC. (US) | 2005-07-28 | — | — | US | claimed |
| US-6884783-B2 | 7-Hydroxy chromones as potent antioxidants | UNIGEN PHARMACEUTICALS, INC. (US) | 2005-04-26 | — | — | US | claimed |
| EP-1503777-A1 | 7-HYDROXY CHROMONES AS POTENT ANTIOXIDANTS | Unigen Pharmaceuticals, Inc. (US) | 2005-02-09 | — | — | EP | claimed |
| WO-2003092713-A1 | 7-HYDROXY CHROMONES AS POTENT ANTIOXIDANTS | UNIGEN PHARMACEUTICALS, INC. (US) | 2003-11-13 | — | — | WO | claimed |
| US-20030207818-A1 | Identification and purification of 7-hydroxychromes that exhibit potent antioxidant activity. In one embodiment the present invention includes a method for providing an antioxidant to a host in need thereof, comprising | UNIGEN, INC. | 2003-11-06 | — | — | US | claimed |
| JP-10245391-A | — | — | None | — | — | JP | disclosed |
| EP-4662319-A2 | PERSONALIZED CRISPR PROFILING FOR CANCER | Integrate Bioscience LLC (US) | 2025-12-17 | — | — | EP | disclosed |
| CN-121005692-A | Burisperidone efficient synthesis method of (2) | 山东新时代药业有限公司 | 2025-11-25 | — | — | CN | disclosed |
| CN-120289476-A | Synthesis method of drug intermediate | 安徽大学 | 2025-07-11 | — | — | CN | disclosed |
| EP-0021827-B1 | POLYALKYLHYDROXYCHROMENE AND PROCESS FOR PREPARING THE SAME | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1983-05-11 | — | — | EP | disclosed |
| US-4323505-A | HERBICIDES, FUNGICIDES | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1982-04-06 | — | — | US | disclosed |
| EP-0021827-A1 | Polyalkylhydroxychromene and process for preparing the same | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1981-01-07 | — | — | EP | disclosed |
| US-3989724-A | Tetrahydropyran-2-ols | HOFFMANN-LA ROCHE INC. (US) | 1976-11-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100168223-A1 | 7-Hydroxy Chromones As Potent Antioxidants | CYP27A1, NOX4, ROS1 | STS 1665/4885CYP3A4 94/4885CA2 2013/4885 |
| US-20030207818-A1 | Identification and purification of 7-hydroxychromes that exhibit potent antioxidant activity. In one embodiment the present invention includes a method for providing an antioxidant to a host in need thereof, comprising | NQO1, KEAP1, NOX4 | STS 1659/4885CYP3A4 139/4885CA2 1700/4885 |
| US-20050164957-A1 | 7-Hydroxy chromones as potent antioxidants | CYP27A1, NOX4, ROS1 | STS 1665/4885CYP3A4 94/4885CA2 2013/4885 |
| US-20130012458-A1 | 7-HYDROXY CHROMONES AS POTENT ANTIOXIDANTS | CYP27A1, ROS1, CYP27B1 | STS 2932/4885CYP3A4 276/4885CA2 3569/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.